Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/ski2.54 http://scihub22266oqcxt.onion/10.1002/ski2.54 34235510!8236977!34235510     free     free     free       Skin+Health+Dis 2021 ; 1 (3): e54 Nephropedia Template TP {{tp|p=34235510|t=2021. Outcomes of patients with chronic plaque psoriasis and hidradenitis suppurativa on biologic therapy during the Covid-19 pandemic: A UK dermatology tertiary centre experience |pdf=|usr=}}{{34235510}} gab.com Text Outcomes of patients with chronic plaque psoriasis and hidradenitis suppurativa on biologic therapy during the Covid-19 pandemic: A UK dermatology tertiary centre experience JO: Skin Health Dis http://www.kidney.de/pget.php?&tw=1&pmid=34235510 #FOAvip Retrospective review data from 183 patients with psoriasis and/or hidradenitis suppurativa from a UK tertiary dermatology centre, suggests biologic therapy does not confer a significant increased risk of contracting severe Covid-19 in this cohort. This is in line with a growing body of evidence which indicates that it is safe to continue using biologic therapies during the pandemic. Twit Text FOAVip Outcomes of patients with chronic plaque psoriasis and hidradenitis suppurativa on biologic therapy during the Covid-19 pandemic: A UK dermatology tertiary centre experience ????Skin Health Dis http://www.kidney.de/pget.php?&tw=1&pmid=34235510 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34235510 #FOAvip English Wikipedia <ref>{{Cite pmid|34235510}}</ref> Outcomes of patients with chronic plaque psoriasis and hidradenitis suppurativa on biologic therapy during the Covid-19 pandemic: A UK dermatology tertiary centre experience #MMPMID34235510 Khan S; Karponis D; Wali G Skin Health Dis 2021[Sep]; 1 (3): e54 PMID34235510show ga Retrospective review data from 183 patients with psoriasis and/or hidradenitis suppurativa from a UK tertiary dermatology centre, suggests biologic therapy does not confer a significant increased risk of contracting severe Covid-19 in this cohort. This is in line with a growing body of evidence which indicates that it is safe to continue using biologic therapies during the pandemic. ?Outcomes of patients with chronic plaque psoriasis and hidradenitis su(epmc).pdf DeepDyve Pubget Overpricing